Nesivine Pädiatrie Sine Conservans (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride is a topical nasal decongestant that reduces swelling of the nasal mucosa.

• Nasal congestion: provides rapid, temporary relief of blocked nose caused by colds, sinusitis or allergic rhinitis.
• Common cold: eases breathing difficulty associated with upper respiratory viral infections.
• Allergic rhinitis: diminishes nasal blockage due to seasonal or perennial allergens.

• Oxymetazoline Hydrochloride acts as a selective alpha‑1 and alpha‑2 adrenergic receptor agonist on the vascular smooth muscle of the nasal mucosa. Activation of these receptors induces vasoconstriction, which reduces blood flow, edema, and consequently nasal airway obstruction, delivering prompt decongestant effect.

Oxymetazoline Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nasal irritation or burning sensation.
• Dryness of the nasal passages.
• Sneezing or mild epistaxis.
• Headache.
• Transient taste disturbance.
• Rebound congestion with prolonged use.

Serious or Rare Side Effects

• Severe hypertension or hypertensive crisis.
• Cardiac arrhythmias.
• Nasal ulceration or necrosis.
• Anaphylactic reaction.
• Vision changes or ocular pressure increase.
• Persistent severe headache.

Before using Oxymetazoline Hydrochloride, consider the following safety measures.

• Limit duration of use: do not exceed three consecutive days to avoid rebound congestion.
• Pre‑existing cardiovascular disease: use with caution and monitor blood pressure.
• Diabetes or thyroid disorders: consult a healthcare professional before use.
• Children under a certain age: follow age‑specific recommendations on the product label.
• Pregnancy and breastfeeding: discuss potential risks with a physician.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline Hydrochloride can interact with other medications that affect blood pressure or adrenergic pathways.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may cause excessive hypertensive response.
• Other nasal decongestants: risk of additive vasoconstriction and rebound effects.
• Tricyclic antidepressants: can potentiate cardiovascular stimulation.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may blunt the systemic cardiovascular response.
• Clonidine or other antihypertensives: monitor for additive blood pressure changes.
• Sympathomimetic agents: assess for cumulative adrenergic effects.